Cargando…
3D-QSAR, Molecular Docking, and MD Simulations of Anthraquinone Derivatives as PGAM1 Inhibitors
PGAM1 is overexpressed in a wide range of cancers, thereby promoting cancer cell proliferation and tumor growth, so it is gradually becoming an attractive target. Recently, a series of inhibitors with various structures targeting PGAM1 have been reported, particularly anthraquinone derivatives. In p...
Autores principales: | Wang, Yuwei, Guo, Yifan, Qiang, Shaojia, Jin, Ruyi, Li, Zhi, Tang, Yuping, Leung, Elaine Lai Han, Guo, Hui, Yao, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656170/ https://www.ncbi.nlm.nih.gov/pubmed/34899321 http://dx.doi.org/10.3389/fphar.2021.764351 |
Ejemplares similares
-
Discovery of Novel IDH1 Inhibitor Through Comparative Structure-Based Virtual Screening
por: Wang, Yuwei, et al.
Publicado: (2020) -
Recent advances of IDH1 mutant inhibitor in cancer therapy
por: Tian, Wangqi, et al.
Publicado: (2022) -
Pharmacokinetics of Anthraquinones from Medicinal Plants
por: Wang, Dongpeng, et al.
Publicado: (2021) -
QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
por: Song, Fucheng, et al.
Publicado: (2023) -
Role of anthraquinones in combating insulin resistance
por: Xia, Wanru, et al.
Publicado: (2023)